Further investigation into the underlying mechanisms revealed that SV2A, as a binding protein of APP, could reduce amyloidosis of APP by inhibiting the binding of BACE1 to APP and regulating the intracellular distribution of APP. The gene discussed is APP; the disease is amyloidosis.